Author Response to: Comment from Cheng Gu and Yu Cui on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan

被引：0
|
作者：
Iki, Masayuki [1 ,8 ]
Fujimori, Kenji [2 ,8 ]
Okimoto, Nobukazu [3 ,8 ]
Nakatoh, Shinichi [4 ,8 ]
Tamaki, Junko [5 ,8 ]
Ishii, Shigeyuki [6 ,8 ]
Imano, Hironori [1 ]
Ogawa, Sumito [7 ,8 ]
机构：
[1] Kindai Univ, Dept Publ Hlth, Fac Med, 377-2 Oono Higashi, Osaka 5898511, Japan
[2] Tohoku Univ, Sch Med, Dept Hlth Adm & Policy, 2-1 Seiryo machi,Aoba Ku, Sendai, Miyagi 9808575, Japan
[3] Okimoto Clin, 185-4 Kubi,Yutaka machi, Kure, Hiroshima 7340304, Japan
[4] Asahi Gen Hosp, Dept Orthoped Surg, 477 Tomari, Asahimachi, Toyama 9390798, Japan
[5] Osaka Med & Pharmaceut Univ, Dept Hyg & Publ Hlth, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan
[6] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Regulatory Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1930392, Japan
[7] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan
[8] Kindai Univ, Fac Med, Natl Database Japan Osteoporosis Management NDBJ O, Dept Publ Hlth, 377-2 Oono Higashi, Osakasayama, Osaka 5898511, Japan
来源：
OSTEOPOROSIS INTERNATIONAL | 2025年 / 36卷 / 02期
关键词：
D O I：
10.1007/s00198-024-07333-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 360
页数：2
相关论文
共 10 条
  • [1] Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
    Cao, Dongdong
    Cao, Zhiyang
    Liu, Aifeng
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (02) : 361 - 362
  • [2] Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
    Iki, Masayuki
    Fujimori, Kenji
    Okimoto, Nobukazu
    Nakatoh, Shinichi
    Tamaki, Junko
    Ishii, Shigeyuki
    Imano, Hironori
    Ogawa, Sumito
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (01) : 81 - 92
  • [3] Author Response to: Comment from Zahra Ali Haque, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
    Iki, Masayuki
    Fujimori, Kenji
    Okimoto, Nobukazu
    Nakatoh, Shinichi
    Tamaki, Junko
    Ishii, Shigeyuki
    Imano, Hironori
    Ogawa, Sumito
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (02) : 367 - 368
  • [4] Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan Response
    Iki, Masayuki
    Fujimori, Kenji
    Okimoto, Nobukazu
    Nakatoh, Shinichi
    Tamaki, Junko
    Ishii, Shigeyuki
    Imano, Hironori
    Ogawa, Sumito
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (02) : 363 - 364
  • [5] Long-term survival after major trauma: a retrospective nationwide cohort study from the National Health Insurance Research Database
    Kuo, Ling-Wei
    Wang, Yu-Hsin
    Wang, Chia-Cheng
    Huang, Yu-Tung A.
    Hsu, Chih-Po
    Tee, Yu-San
    Chen, Szu-An
    Liao, Chien-An
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (12) : 4041 - 4048
  • [6] Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan
    Iki, Masayuki
    Fujimori, Kenji
    Nakatoh, Shinichi
    Tamaki, Junko
    Ishii, Shigeyuki
    Okimoto, Nobukazu
    Imano, Hironori
    Ogawa, Sumito
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (05) : 805 - 818
  • [7] Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan
    Masayuki Iki
    Kenji Fujimori
    Shinichi Nakatoh
    Junko Tamaki
    Shigeyuki Ishii
    Nobukazu Okimoto
    Hironori Imano
    Sumito Ogawa
    Osteoporosis International, 2024, 35 : 805 - 818
  • [8] A survey of clarithromycin monotherapy and long-term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims
    Iwao, Tomohide
    Kato, Genta
    Ito, Isao
    Aramaki, Eiji
    Kuroda, Tomohiro
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (04) : 427 - 432
  • [9] Delayed initiation of anti-osteoporosis medications increases subsequent hip and vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan
    Iki, Masayuki
    Fujimori, Kenji
    Nakatoh, Shinichi
    Tamaki, Junko
    Ishii, Shigeyuki
    Okimoto, Nobukazu
    Kamiya, Kuniyasu
    Ogawa, Sumito
    BONE, 2022, 160
  • [10] Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan
    Iki, Masayuki
    Fujimori, Kenji
    Nakatoh, Shinichi
    Tamaki, Junko
    Ishii, Shigeyuki
    Okimoto, Nobukazu
    Kamiya, Kuniyasu
    Ogawa, Sumito
    BONE, 2023, 166
1